MELISSA BITSURA: Open Payments
NPI 1629808944 · CORAOPOLIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,942 in 190 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $1,232 · 2025 $3,942
Food & beverage: $3,843Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 51 | $1,002 |
| Janssen Biotech, Inc. | 33 | $715 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $485 |
| Ardelyx, Inc. | 10 | $255 |
| Regeneron Healthcare Solutions, Inc. | 8 | $237 |
| PFIZER INC. | 14 | $211 |
| Ipsen Biopharmaceuticals, Inc | 8 | $210 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $176 |
| Madrigal Pharmaceuticals | 11 | $141 |
| Celltrion USA Inc. | 6 | $125 |
Products named: TREMFYA, RINVOQ, ENTYVIO, SKYRIZI, IBSRELA, DUPIXENT, IQIRVO, XIFAXAN.
Industry payments across PA — which companies pay providers there.
